LJKR · # %( $) * ) :89@ ? ,).) )& 0 ,-#)( k9l9l dlk /!/-. ljkre ? ! :) :? ! $ $#) #)( k ' ,! ( 3 /,! ,3 )"),. ./ 3 . ,#(! )''#.. 9999999999999999999999999999999999999999 m

ACUTE COMPLICATED CALCULOUS BILIARY DISEASEPOPULATION

Patients admitted to participating hospitals

during study period 01/10/18 - 31/10/18

(Follow-up to 31/12/18)

OBSERVATIONS

PATHOLOGIES OUTCOME MEASURES

Diagnostic Imaging used (US, CT, MRI)

cholecystitis

ICU Admission

Surgical Complications requiring re-operation or radiologic or endoscopic intervention (Clavien-Dindo IIIa or above)

European Society for Trauma and Emergency Surgery

Snapshot Audit

2018

IV fluid requirements Antimicrobial therapy

Primary Surgical intervention & complications (laparoscopic vs open)

Primary & Secondary Endoscopic & Radiologic interventions (and complications)

Overall and Disease-related Mortality

Overall, pre-procedure and post-procedure Length of stay

biliary pancreatitis

Cost analysisGB perforation GB empyema Liver abscess

pseudocyst necrosis abscess

METHODS• Prospective 30-day observational

cohort study, with 60-day follow-up • Validated methodology • REDCap database (secure) • Authorship and data-ownership

for collaborators

Gary Bass (IE)*, Andreas Shamiyeh (AU), Jorge Pereira (PT), Hayato Kurihara (IT), Shahin Mohseini (SWE), Alan Biloslavo (IT), Andrei Mihailescu(UK). *(chair)

STEERING GROUP

CBD stones

oo

ooo

•••

•••

• • • • •

• • • •

• • • • •

• • •

•• •

• •

•

•• • • • •